Related references
Note: Only part of the references are listed.MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome (vol 107, pg 967, 2012)
J. Ryan et al.
BRITISH JOURNAL OF CANCER (2012)
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition
Martina Cozzi et al.
CELL CYCLE (2012)
Potential of microRNAs for cancer diagnostics, prognostication and therapy
Ramiro Garzon et al.
CURRENT OPINION IN ONCOLOGY (2012)
CDC25 Phosphatase Inhibitors: An Update
A. Lavecchia et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
WEE1 Inhibition Sensitizes Basal Breast Cancer Cells to TRAIL-Induced Apoptosis
Sireesha V. Garimella et al.
MOLECULAR CANCER RESEARCH (2012)
Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
Junqing Chen et al.
MEDICAL ONCOLOGY (2012)
Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication
Claus Storgaard Sorensen et al.
NUCLEIC ACIDS RESEARCH (2012)
Genome-Wide MicroRNA Expression Analysis of Clear Cell Renal Cell Carcinoma by Next Generation Deep Sequencing
Susanne Osanto et al.
PLOS ONE (2012)
Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression
Xiaohong Wang et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2012)
The p53 network: cellular and systemic DNA damage responses in aging and cancer
H. Christian Reinhardt et al.
TRENDS IN GENETICS (2012)
WEE1 inhibition sensitizes osteosarcoma to radiotherapy
Jantine PosthumaDeBoer et al.
BMC CANCER (2011)
MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
N. V. Rajeshkumar et al.
CLINICAL CANCER RESEARCH (2011)
WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
Philip C. De Witt Hamer et al.
CLINICAL CANCER RESEARCH (2011)
MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway
Ralph Gruber et al.
NATURE CELL BIOLOGY (2011)
starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data
Jian-Hua Yang et al.
NUCLEIC ACIDS RESEARCH (2011)
Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome
Lyndsay M. Murrow et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
MK-1775, a small molecule Wee1 inhibitor, enhances antitumor efficacy of various DNA-damaging agents, including 5-fluorouracil
Hiroshi Hirai et al.
CANCER BIOLOGY & THERAPY (2010)
In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
Shahryar E. Mir et al.
CANCER CELL (2010)
Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas
Henriett Butz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
microRNAs regulate human embryonic stem cell division
Junlin Qi et al.
CELL CYCLE (2009)
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
Hiroshi Hirai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
Elizabeth Iorns et al.
PLOS ONE (2009)
In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
Hiroaki Kiyokawa et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis
Steffen Blenk et al.
BMC CANCER (2008)
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c
C. Nakada et al.
JOURNAL OF PATHOLOGY (2008)
Activity of novel Cdc25 inhibitors and preliminary evaluation of their potentiation of chemotherapeutic drugs in human breast cancer cells
Laurent Brault et al.
LIFE SCIENCES (2008)
Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas
Yoo-Jin Kim et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement
Taija M. Kiviharju-af Hallstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Knockdown of Chk1, Wee1 and Myt1 by RNA interference abrogates G2 checkpoint and induces apoptosis
YL Wang et al.
CANCER BIOLOGY & THERAPY (2004)
The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer
T Yoshida et al.
ANNALS OF ONCOLOGY (2004)
Cdc25 phosphatases and cancer
K Kristjánsdóttir et al.
CHEMISTRY & BIOLOGY (2004)
Cyclins and cyclin-dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis
T Masaki et al.
HEPATOLOGY (2003)
Share Paper
